Vigil Health Solutions Reports Revenue/Bookings Growth and Profitable Fourth Quarter and Fiscal Year Results

Vigil Health Solutions Inc. ("Vigil") (TSX VENTURE:VGL) announces the results of
operations for the fiscal year and the fourth quarter, ending March 31, 2013.


Highlights 



--  Earnings of $153 thousand for fiscal 2013 compared to a loss of $425
    thousand in fiscal 2012. 
--  Positive EBIDTA of $207 thousand compared to negative EBITDA of $399
    thousand in fiscal 2012. 
--  Revenue up 11% to $3.74 million compared to $3.37 million in the year
    ended March 31, 2012. 
--  Sales bookings were up 18% for the year to $4.41 million compared to
    $3.73 million in the year ended March 31, 2012. 
--  Gross margin percentage was 49% compared to 46% for fiscal 2012. 
--  Operating expenditures down 14% to $1.69 million from $1.98 million for
    year ended March 31, 2012. 
--  Completed development and deployment of the Vigil ZLink, a component of
    the new Vitality Care System designed to work for stand alone buildings
    on large senior living campuses. 
--  Subsequent to year end, in the week ended May 31, 2013, 3,844,613 common
    shares were purchased for gross proceeds of $388 thousand following the
    exercise of warrants.  



"We are pleased to see positive earnings for fiscal 2013. As a Company we are
committed to providing practical innovation combined with the best customer
service. This year's earnings are the result not only of a great product but a
great team. The commitment to the Company, the product and the customer shown by
all team members was essential to our fiscal 2013 results." stated Troy
Griffiths, President and CEO of Vigil Health Solutions Inc.


Financial Results

Sales bookings for the year ended March 31, 2013 were $4.41 million up from
$3.73 million in the year ended March 31, 2012.


At March 31, 2013 Vigil had a backlog of approximately $3.62 million (including
$899 thousand in deposits and progress billings, recorded as deferred revenue on
the balance sheet) up 88% from $1.93 million (including $394 thousand in
deposits and progress billings, recorded as deferred revenue on the balance
sheet) at March 31, 2012.


Vigil records revenue following completion of the installation and commissioning
of the product at the customer site which is indicated by customer acceptance.
The timing of the installation of Vigil's products is often dependent on
facility construction schedules, which can result in a considerable lag between
receipt of contracts and revenue recognition. The Company's backlog includes all
contracts signed including those in progress but not completed.


Revenue for the year ended March 31, 2013 was $3.74 million compared to $3.37
million in the year ended March 31, 2012, an increase of 11%. Project revenue
made up 60% of total revenue; the remaining revenue came from follow on sales to
existing customers. These sales include service and maintenance billings and
replacement products including wireless devices and communication equipment and
were up 7% over fiscal 2012.


The gross margin percentage for the year ended March 31, 2013 was 49% compared
to 46% for the year ended March 31, 2012. Gross margins have been better than
management expectations of between 42% and 47%. This relates to a number of
factors including more efficient staffing of project commissioning and product
mix.


Operating expenditures for the year ended March 31, 2013 were $1.69 million down
14% from $1.98 million for the same period ended March 31, 2012. Expenses
increased in the last quarter of fiscal 2013 in line with the increased business
activity.


Net income for the year ended March 31, 2013 was $153 thousand, or $0.012 per
share, compared to losses of $425 thousand, or $0.036 per share, for the
previous year. The profitable year is due to improved revenue and the $325
thousand decrease in operating expenses.


A summary of our financial performance for the quarter and year ended March 31,
2013 follows below. For further information relating to the financial results of
the Company, please refer to the Company's financial statements and MD&A filed
on SEDAR at www.sedar.com. Financial information will be mailed to entitled
security holders on June 28, 2013. Or, upon notice to the Company, entitled
security holders may request a copy of financials in advance. 




Summary Financial Information

-------------------------------------------------------------------------
                                 Three months end       Twelve months end
                                         March 31,               March 31,
                                 2013        2012        2013        2012
-------------------------------------------------------------------------
Revenue                   $ 1,141,721 $   901,674 $ 3,737,550 $ 3,370,733
Cost of sales                 581,412     499,482   1,893,247   1,822,603
-------------------------------------------------------------------------
Gross profit                  560,309     402,192   1,844,303   1,548,130
Expenses                      511,364     453,871   1,691,821   1,976,845
-------------------------------------------------------------------------
Income (loss) before the                                                 
 following items               48,945     (51,679)    152,482    (428,715)
Other income (expense)          1,811       1,631         844       3,991
-------------------------------------------------------------------------
Comprehensive income                                                     
 (loss) for the period    $    50,756 $   (50,048)$   153,326 $  (424,724)
-------------------------------------------------------------------------



Non-IFRS Measure

For the year ended March 31, 2013, we are disclosing Adjusted EBITDA, a non-IFRS
financial measure, as a supplementary indicator of operating performance. We
define Adjusted EBITDA as net income before, interest, income taxes,
amortization, stock based compensation and currency gains or losses including
derivative foreign exchange differences. We are presenting the non-IFRS
financial measure in our filings because we use it internally to make strategic
decisions, forecast future results and to evaluate our performance and because
we believe that our current and potential investors and analysts use the measure
to assess current and future operating results and to make investment decisions.
It is a non-IFRS measure, may not be comparable to other companies and it is not
intended as a substitute for IFRS measures.




Adjusted EBITDA reconciliation

-------------------------------------------------------------------------
                               Three months ended     Twelve months ended
                             March 31,   March 31,   March 31,   March 31,
                                 2013        2012        2013        2012
-------------------------------------------------------------------------
Income / (loss) for the                                                  
 period                       $50,756    $(50,048)   $153,326   $(424,724)
                                                                         
Add / (deduct)                                                           
 Foreign exchange gain                                                   
  (loss)                       (7,095)     (2,385)    (23,826)    (11,586)
 Derivative exchange gain       3,478      (2,423)      9,200      (7,711)
 Interest                       1,805       3,177      13,782      15,306
 Stock based compensation      12,478       1,341      39,290       7,370
 Amortization                   3,603       4,825      15,646      22,583
-------------------------------------------------------------------------
                               14,269       4,535      54,092      25,962
-------------------------------------------------------------------------
Adjusted EBITDA               $65,025    $(45,513)   $207,418   $(398,762)
-------------------------------------------------------------------------



About Vigil Health Solutions Inc.

Vigil offers a proprietary technology platform combining software and hardware
to provide comprehensive solutions to the expanding seniors' housing market.
Vigil has established a growing presence in North America and an international
reputation for being on the leading edge of systems design and integration.
Vigil's objective is to offer solutions for the full continuum of care. Vigil's
product range includes the innovative wireless Vitality Care System(TM)
featuring discreet 'mini pendants', a nurse call system, mobile fall,
incontinence monitoring, resident check in and the award-winning Vigil Dementia
System.


Certain statements contained in this news release, that are not based on
historical facts, may constitute forward-looking statements or forward-looking
information within the meaning of applicable securities laws ("forward-looking
statements"). These forward-looking statements are not promises or guarantees of
future performance but are only predictions that relate to future events,
conditions or circumstances or our future results, performance, achievements or
developments and are subject to substantial known and unknown risks,
assumptions, uncertainties and other factors that could cause our actual
results, performance, achievements or developments in our business or in our
industry to differ materially from those expressed, anticipated or implied by
such forward-looking statements.


Forward-looking statements include all financial guidance, disclosure regarding
possible events, conditions, circumstances or results of operations that are
based on assumptions about future economic conditions, courses of action and
other future events. We caution you not to place undue reliance upon any such
forward-looking statements, which speak only as of the date they are made. These
forward-looking statements appear in a number of different places in this
presentation and can be identified by words such as "may", "estimates",
"projects", "expects", "intends", "believes", "plans", "anticipates", or their
negatives or other comparable words. Forward-looking statements include
statements regarding the outlook for our future operations, plans and timing for
the introduction or enhancement of our services and products, statements
concerning strategies or developments, statements about future market
conditions, supply conditions, end customer demand conditions, channel inventory
and sell through, revenue, gross margin, operating expenses, profits, forecasts
of future costs and expenditures, the outcome of legal proceedings, and other
expectations, intentions and plans that are not historical fact.


The risk factors and uncertainties that may affect our actual results,
performance, achievements or developments are many and include, amongst others,
our ability to develop our sales force and generate revenue, the length of the
sales cycle, management of the Company's growth, ability to recruit and retain
staff, fluctuations in demand for current and future products, our ability to
develop, manufacture, supply and market existing and new products that meet the
needs of customers, volatility in the exchange rate, ability to secure
financing, ability to secure product liability insurance, the continuous
commitment of our customers, increased competition, changes in regulation and
reliance on third party suppliers. These risk factors and others are discussed
in the Risks and Uncertainties section of our Management Discussion and
Analysis. Many of these factors and uncertainties are beyond the control of the
Company. Consequently, all forward-looking statements in this news release are
qualified by this cautionary statement and there can be no assurance that actual
results, performance, achievements or developments anticipated by the Company
will be realized. 


Forward-looking statements are based on management's current plans, estimates,
projections, beliefs and opinions and, except as required by law, the Company
does not undertake any obligation to update forward-looking statements should
the assumptions related to these plans, estimates, projections, beliefs and
opinions change.


The TSX Venture Exchange has not reviewed and does not accept responsibility for
the adequacy or accuracy of this release


FOR FURTHER INFORMATION PLEASE CONTACT: 
Vigil Health Solutions Inc.
Troy Griffiths
President and CEO
[phone]
[phone] (FAX)
[e-mail]
www.vigil.com